Status: Recruiting
SELUTION4BTK Trial
This study aims to demonstrate superior efficacy and equivalent safety of the SELUTION SLR™ DEB 014 compared to plain (uncoated) balloon angioplasty in the treatment of peripheral arterial disease (PAD) in the BTK arteries in CLTI patients.
Participants needed: 376
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: M.A. Med Alliance S.A.Updated: Apr 28, 2026Locations: 48
Eligibility criteria
Subject age is ≥ 18 years or older depending on local regulations. [+17]
Osteomyelitis involving proximal to the metatarsal head(s) [+35]